Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1994 Jan;95(1):128–134. doi: 10.1111/j.1365-2249.1994.tb06026.x

The effect of anti-CD4 on helper function of CD4,45RA+ versus CD4,45RO+ T cells.

J Wang 1, T Yan 1, B Simmer 1, F Emmrich 1
PMCID: PMC1534612  PMID: 8287596

Abstract

Here we have investigated and compared the effects of anti-CD4 on helper function of CD4,45RA+ versus CD4,45RO+ T cells. Only CD4,45RO+ cells, but not CD4,45RA+ cells were able to promote B cell differentiation resulting in immunoglobulin production in vitro (IgM as well as IgG) which could be inhibited by anti-CD4 MoAbs (MAX.16H5 and T151). In pokeweed mitogen (PWM)-induced B cell proliferation a similar pattern of responsiveness was obtained. When we studied the anti-CD4 effects on cytokine production in T cells stimulated in mixed lymphocyte reaction (MLR) or by mitogens, we found that neither IL-2 nor IL-4 production was dramatically influenced by anti-CD4 in CD4,45RO+ cells. This led us to the conclusion that the inhibitory effect of anti-CD4 on B cell proliferation and immunoglobulin secretion was not due to inhibition of cytokine production. To clarify this point, we investigated the ability of anti-CD4 to inhibit conjugate formation between B and T cells. It was found that CD4,45RO+ T cells formed more conjugates than CD4,45RA+ cells, and that only the conjugate formation by CD4,45RO+ T cells was inhibited by anti-CD4. These results suggest that (i) anti-CD4 inhibits T helper functions primarily by affecting CD4,45RO+ cells, and (ii) this effect is probably mediated by contact inhibition in the early phase of T-B collaboration.

Full text

PDF
130

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akbar A. N., Salmon M., Janossy G. The synergy between naive and memory T cells during activation. Immunol Today. 1991 Jun;12(6):184–188. doi: 10.1016/0167-5699(91)90050-4. [DOI] [PubMed] [Google Scholar]
  2. Andersson U., Andersson J., Lindfors A., Wagner K., Möller G., Heusser C. H. Simultaneous production of interleukin 2, interleukin 4 and interferon-gamma by activated human blood lymphocytes. Eur J Immunol. 1990 Jul;20(7):1591–1596. doi: 10.1002/eji.1830200727. [DOI] [PubMed] [Google Scholar]
  3. Bell E. B., Sparshott S. M. Interconversion of CD45R subsets of CD4 T cells in vivo. Nature. 1990 Nov 8;348(6297):163–166. doi: 10.1038/348163a0. [DOI] [PubMed] [Google Scholar]
  4. Bettens F., Walker C., Gauchat J. F., Gauchat D., Wyss T., Pichler W. J. Lymphokine gene expression related to CD4 T cell subset (CD45R/CDw29) phenotype conversion. Eur J Immunol. 1989 Sep;19(9):1569–1574. doi: 10.1002/eji.1830190908. [DOI] [PubMed] [Google Scholar]
  5. Byrne J. A., Butler J. L., Reinherz E. L., Cooper M. D. Virgin and memory T cells have different requirements for activation via the CD2 molecule. Int Immunol. 1989;1(1):29–35. doi: 10.1093/intimm/1.1.29. [DOI] [PubMed] [Google Scholar]
  6. Dianzani U., Luqman M., Rojo J., Yagi J., Baron J. L., Woods A., Janeway C. A., Jr, Bottomly K. Molecular associations on the T cell surface correlate with immunological memory. Eur J Immunol. 1990 Oct;20(10):2249–2257. doi: 10.1002/eji.1830201014. [DOI] [PubMed] [Google Scholar]
  7. Emmrich F., Horneff G., Becker W., Lüke W., Potocnik A., Kanzy U., Kalden J. R., Burmester G. An anti-CD4 antibody for treatment of chronic inflammatory arthritis. Agents Actions Suppl. 1991;32:165–170. doi: 10.1007/978-3-0348-7405-2_22. [DOI] [PubMed] [Google Scholar]
  8. Emmrich F., Moll H., Simon M. M. Recombinant human interleukin 2 acts as a B cell growth and differentiation promoting factor. Immunobiology. 1985 Feb;169(1):97–102. doi: 10.1016/S0171-2985(85)80057-7. [DOI] [PubMed] [Google Scholar]
  9. Emmrich F., Schilling B., Eichmann K. Human immune response to group A streptococcal carbohydrate (A-CHO). I. Quantitative and qualitative analysis of the A-CHO-specific B cell population responding in vitro to polyclonal and specific activation. J Exp Med. 1985 Mar 1;161(3):547–562. doi: 10.1084/jem.161.3.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fujii Y., Okumura M., Inada K., Nakahara K., Matsuda H. CD45 isoform expression during T cell development in the thymus. Eur J Immunol. 1992 Jul;22(7):1843–1850. doi: 10.1002/eji.1830220725. [DOI] [PubMed] [Google Scholar]
  11. Hafler D. A., Weiner H. L. Immunosuppression with monoclonal antibodies in multiple sclerosis. Neurology. 1988 Jul;38(7 Suppl 2):42–47. [PubMed] [Google Scholar]
  12. Herzog C., Walker C., Pichler W., Aeschlimann A., Wassmer P., Stockinger H., Knapp W., Rieber P., Müller W. Monoclonal anti-CD4 in arthritis. Lancet. 1987 Dec 19;2(8573):1461–1462. doi: 10.1016/s0140-6736(87)91158-5. [DOI] [PubMed] [Google Scholar]
  13. Hiepe F., Volk H. D., Apostoloff E., von Baehr R., Emmrich F. Treatment of severe systemic lupus erythematosus with anti-CD4 monoclonal antibody. Lancet. 1991 Dec 14;338(8781):1529–1530. doi: 10.1016/0140-6736(91)92353-4. [DOI] [PubMed] [Google Scholar]
  14. Hirohata S., Jelinek D. F., Lipsky P. E. T cell-dependent activation of B cell proliferation and differentiation by immobilized monoclonal antibodies to CD3. J Immunol. 1988 Jun 1;140(11):3736–3744. [PubMed] [Google Scholar]
  15. Hirohata S., Lipsky P. E. T cell regulation of human B cell proliferation and differentiation. Regulatory influences of CD45R+ and CD45R- T4 cell subsets. J Immunol. 1989 Apr 15;142(8):2597–2607. [PubMed] [Google Scholar]
  16. Holter W., Majdic O., Kalthoff F. S., Knapp W. Regulation of interleukin-4 production in human mononuclear cells. Eur J Immunol. 1992 Oct;22(10):2765–2767. doi: 10.1002/eji.1830221047. [DOI] [PubMed] [Google Scholar]
  17. Horneff G., Burmester G. R., Emmrich F., Kalden J. R. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum. 1991 Feb;34(2):129–140. doi: 10.1002/art.1780340202. [DOI] [PubMed] [Google Scholar]
  18. Jelinek D. F., Lipsky P. E. Regulation of human B lymphocyte activation, proliferation, and differentiation. Adv Immunol. 1987;40:1–59. doi: 10.1016/s0065-2776(08)60237-0. [DOI] [PubMed] [Google Scholar]
  19. Koretzky G. A., Picus J., Thomas M. L., Weiss A. Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway. Nature. 1990 Jul 5;346(6279):66–68. doi: 10.1038/346066a0. [DOI] [PubMed] [Google Scholar]
  20. Koulova L., Yang S. Y., Dupont B. Identification of the anti-CD3-unresponsive subpopulation of CD4+, CD45RA+ peripheral T lymphocytes. J Immunol. 1990 Oct 1;145(7):2035–2043. [PubMed] [Google Scholar]
  21. Lecomte O., Fischer A. Antigen-independent adhesion of CD45RA (naive) and CD45RO (memory) CD4 T cells to B cells. Int Immunol. 1992 Feb;4(2):191–196. doi: 10.1093/intimm/4.2.191. [DOI] [PubMed] [Google Scholar]
  22. Mond J. J., Thompson C., Finkelman F. D., Farrar J., Schaefer M., Robb R. J. Affinity-purified interleukin 2 induces proliferation of large but not small B cells. Proc Natl Acad Sci U S A. 1985 Mar;82(5):1518–1521. doi: 10.1073/pnas.82.5.1518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mustelin T., Coggeshall K. M., Altman A. Rapid activation of the T-cell tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phosphatase. Proc Natl Acad Sci U S A. 1989 Aug;86(16):6302–6306. doi: 10.1073/pnas.86.16.6302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Noelle R. J., Daum J., Bartlett W. C., McCann J., Shepherd D. M. Cognate interactions between helper T cells and B cells. V. Reconstitution of T helper cell function using purified plasma membranes from activated Th1 and Th2 T helper cells and lymphokines. J Immunol. 1991 Feb 15;146(4):1118–1124. [PubMed] [Google Scholar]
  25. Noelle R. J., Ledbetter J. A., Aruffo A. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol Today. 1992 Nov;13(11):431–433. doi: 10.1016/0167-5699(92)90068-I. [DOI] [PubMed] [Google Scholar]
  26. Ostergaard H. L., Shackelford D. A., Hurley T. R., Johnson P., Hyman R., Sefton B. M., Trowbridge I. S. Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8959–8963. doi: 10.1073/pnas.86.22.8959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Paul W. E., Ohara J. B-cell stimulatory factor-1/interleukin 4. Annu Rev Immunol. 1987;5:429–459. doi: 10.1146/annurev.iy.05.040187.002241. [DOI] [PubMed] [Google Scholar]
  28. Ranges G. E., Sriram S., Cooper S. M. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med. 1985 Sep 1;162(3):1105–1110. doi: 10.1084/jem.162.3.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Reiter C., Kakavand B., Rieber E. P., Schattenkirchner M., Riethmüller G., Krüger K. Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration. Arthritis Rheum. 1991 May;34(5):525–536. doi: 10.1002/art.1780340504. [DOI] [PubMed] [Google Scholar]
  30. Rogozinski L., Bass A., Glickman E., Talle M. A., Goldstein G., Wang J., Chess L., Thomas Y. The T4 surface antigen is involved in the induction of helper function. J Immunol. 1984 Feb;132(2):735–739. [PubMed] [Google Scholar]
  31. Salmon M., Kitas G. D., Gaston J. S., Bacon P. A. Interleukin-2 production and response by helper T-cell subsets in man. Immunology. 1988 Sep;65(1):81–85. [PMC free article] [PubMed] [Google Scholar]
  32. Sanders M. E., Makgoba M. W., Sharrow S. O., Stephany D., Springer T. A., Young H. A., Shaw S. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. J Immunol. 1988 Mar 1;140(5):1401–1407. [PubMed] [Google Scholar]
  33. Saxon A., Feldhaus J., Robins R. A. Single step separation of human T and B cells using AET treated srbc rosettes. J Immunol Methods. 1976;12(3-4):285–288. doi: 10.1016/0022-1759(76)90050-8. [DOI] [PubMed] [Google Scholar]
  34. Sedgwick J. D., Holt P. G. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J Immunol Methods. 1983 Feb 25;57(1-3):301–309. doi: 10.1016/0022-1759(83)90091-1. [DOI] [PubMed] [Google Scholar]
  35. Shizuru J. A., Gregory A. K., Chao C. T., Fathman C. G. Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. Science. 1987 Jul 17;237(4812):278–280. doi: 10.1126/science.2955518. [DOI] [PubMed] [Google Scholar]
  36. Shizuru J. A., Taylor-Edwards C., Banks B. A., Gregory A. K., Fathman C. G. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science. 1988 Apr 29;240(4852):659–662. doi: 10.1126/science.2966437. [DOI] [PubMed] [Google Scholar]
  37. Sleasman J. W., Morimoto C., Schlossman S. F., Tedder T. F. The role of functionally distinct helper T lymphocyte subpopulations in the induction of human B cell differentiation. Eur J Immunol. 1990 Jun;20(6):1357–1366. doi: 10.1002/eji.1830200623. [DOI] [PubMed] [Google Scholar]
  38. Streuli M., Hall L. R., Saga Y., Schlossman S. F., Saito H. Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J Exp Med. 1987 Nov 1;166(5):1548–1566. doi: 10.1084/jem.166.5.1548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Suzuki N., Sakane T., Ueda Y., Murakawa Y., Tsunematsu T. Implications for the role of cognate interactions in in vitro human B cell activation by Staphylococcus aureus Cowan I and pokeweed mitogen. J Clin Invest. 1986 Jan;77(1):294–300. doi: 10.1172/JCI112290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Takeuchi T., Schlossman S. F., Morimoto C. The T4 molecule differentially regulating the activation of subpopulations of T4+ cells. J Immunol. 1987 Aug 1;139(3):665–671. [PubMed] [Google Scholar]
  41. Wendling D., Wijdenes J., Racadot E., Morel-Fourrier B. Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis. J Rheumatol. 1991 Mar;18(3):325–327. [PubMed] [Google Scholar]
  42. Wofsy D., Seaman W. E. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. J Immunol. 1987 May 15;138(10):3247–3253. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES